title: [Three-and-a-half years' experience with hemodialysis using 37 Permcaths without infection or definitive thrombosis].
abstract: 34 patients had 37 Quinton Permcath (PKT), surgically implanted in jugular vein (internal: 29, or external: 8). The first 20 were used for a temporary vascular access (mean: 21 weeks). Then, the next 17 were used for permanent vascular access. 8 could be used for more than 1 year and 2 for more than two years. Anti-aggregant (29 cases) or anticoagulant treatment (8 cases) were systematically prescribed. 6 patients died for unrelated causes (mean delay: 35 weeks). 3 catheters were mispositioned. 2 catheters had to be removed because they were damaged (mean 53 and 69 weeks). Complications were: vein thrombosis (internal jugular vein): 2 cases, vein stenosis (inominate vein): 1 case, heparin overdoses: 3 cases. A partial thrombosis of a single lumen was common but always easily cured by local thrombolysis. Nurses were strongly motivated and followed rigorous educations with help of video-movie. This could be why no infectious (local or generalised) complication was observed. Long-term Permcath dialysis is a precious tool for patient without any peripheral vascular access or in elderly and short-live expectancy.
authors.affiliation: Service de Néphrologie Dialyse et Transplantation Rénale, Hôpital Nord, Saint-Priest-en-Jarez.
authors.forename: J
authors.initials: J
authors.lastname: Toulon
authors.forename: C
authors.initials: C
authors.lastname: Broyet
authors.forename: N
authors.initials: N
authors.lastname: Diab
authors.forename: J P
authors.initials: JP
authors.lastname: Favre
authors.forename: J P
authors.initials: JP
authors.lastname: Gournier
authors.forename: J
authors.initials: J
authors.lastname: Jurine
authors.forename: X
authors.initials: X
authors.lastname: Barral
authors.forename: F
authors.initials: F
authors.lastname: Berthoux
mesh_terms: D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D001296:Audiovisual Aids; D001424:Bacterial Infections / Q000517:prevention & control; D002405:Catheterization, Central Venous / Q000009:adverse effects / Q000451:nursing; D002408:Catheters, Indwelling / Q000009:adverse effects; D004868:Equipment Failure; D005260:Female; D006801:Humans; D007601:Jugular Veins; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D006435:Renal Dialysis; D012189:Retrospective Studies; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D013997:Time Factors
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors